Video Library

Lung complications are among the most serious long-term effects that can occur after a bone marrow transplant or CAR T-cell therapy. This presentation reviews the most common pulmonary complications—including bronchiolitis obliterans syndrome (BOS), organizing pneumonia, bronchiectasis, and restrictive lung diseases—and discusses the importance of early diagnosis, routine pulmonary function testing, emerging imaging techniques, new treatment options, and maintaining cardiopulmonary fitness to preserve lung function and quality of life.

CAR T-cell therapy (chimeric antigen receptor T-cell therapy) is a type of immune therapy that uses the body's own immune system to treat cancer. This presentation describes what’s involved in undergoing CAR T-cell therapy, potential side effects and outcomes, and research underway to treat more diseases and improve outcomes and quality of life for CAR T-cell recipients.

This presentation explores the connection between food, the gut microbiome, and chronic disease, introducing a framework called the microbiome-mitochondria axis. Dr. Damman explains how modern, ultra-processed foods strip away key bioactive components—fibers, phytonutrients, bioactive fats, and ferments (the "four Fs")—that the microbiome depends on to produce molecules essential for mitochondrial and overall cellular health. He also addresses nutrition-related questions specific to the transplant community, including fiber tolerance, fermented foods, probiotics, and GI symptom management.

Graft-versus-host disease (GVHD) is a potential complication after a bone marrow/stem cell transplant using donor cells. This presentation explains what GVHD (GVHD) is, the difference between acute and chronic GVHD, risk factors for developing GVHD, how to monitor yourself to catch and report symptoms early, treatment options, and lifestyle changes that can improve GVHD symptoms.

Transplant recipients often experience ongoing issues from their disease and treatment. This presentation describes typical post-transplant complications and how a survivorship plan can help survivors maintain optimal health.

Monitoring and maintaining oral health after transplant is an important part of recovery. This presentation describes typical issues with oral health after transplant, including graft-versus-host disease, and how to treat these conditions effectively.

This presentation provides a detailed explanation of what an autologous stem cell transplant is, who is a good candidate, the steps involved in undergoing an autologous transplant, short- and long-term side effects, and steps survivors can take to maximize their quality of life after transplant.

Dr. Corey Cutler provides an overview of the latest advances in the prevention and treatment of graft-versus-host disease (GVHD), including emerging approaches for both acute and chronic GVHD. He discusses how post-transplant cyclophosphamide (PTCy) has transformed GVHD prevention, as well as promising new strategies involving lower-dose PTCy, ruxolitinib, abatacept, cell-based therapies, and microbiome-based treatments. For chronic GVHD, he highlights newly approved therapies and ongoing research focused on combination treatments, earlier intervention, personalized treatment approaches, and reducing reliance on steroids. The presentation also addresses common patient questions about clinical trials, treatment duration, topical therapies, treatment plateaus, and the relationship between GVHD and relapse.

Bone health is an important part of long-term recovery after bone marrow transplant and CAR T-cell therapy. This presentation explains why transplant recipients are at increased risk for bone loss and fractures, how osteoporosis develops, who should be screened, and what lifestyle changes, nutritional strategies, exercise, and medications can help maintain healthy bones and reduce fracture risk as patients age.

Graft-versus-host disease (GVHD) is a side effect that can occur after an allogeneic bone marrow/stem cell transplant (a transplant using donor cells). This presentation discusses what GVHD is, how it can affect the gastrointestinal (GI) tract, risk factors for developing GI GVHD, symptoms of GI GVHD, treatment options, and strategies patients can use to minimize symptoms and improve outcomes after GI GVHD.

This presentation discusses quality of life after CAR T-cell therapy, potential short-term, late, and long-term side effects, incidence and risk factors for late and long-term side effects, how to monitor yourself for side effects, when and to whom you should report symptoms, and lifestyle changes that can help prevent or manage long-term effects of CAR T-cell therapy.

In this session, leading experts on graft-versus-host disease (GVHD), a common complication after a bone marrow/stem cell transplant, respond to questions about who is at risk of developing GVHD, symptoms of GVHD, and how to manage both the physical and emotional problems associated with GVHD and its treatment.